199 related articles for article (PubMed ID: 24854231)
1. Pyriform sinus squamous cell carcinoma: oncological outcomes in good responders of induction chemotherapy-based larynx preservation protocols.
Vourexakis Z; Le Ridant AM; Dulguerov P; Janot F
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1725-31. PubMed ID: 24854231
[TBL] [Abstract][Full Text] [Related]
2. Larynx preservation protocols: long-term functional outcomes in good responders to induction chemotherapy for pyriform sinus carcinoma.
Vourexakis Z; Janot F; Dulguerov P; Le Ridant AM
ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):165-70. PubMed ID: 25074814
[TBL] [Abstract][Full Text] [Related]
3. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study.
Céruse P; Cosmidis A; Belot A; Rabilloud M; Fuchsmann C; Poupart M; Ramade A; Tartas S; Favrel V; Pommier P; Zrounba P; Fayette J
Anticancer Drugs; 2014 Sep; 25(8):970-5. PubMed ID: 24849707
[TBL] [Abstract][Full Text] [Related]
4. [Long-term outcome of patients with pyriform sinus squamous cell carcinoma treated with planned preoperative (chemo-) radiotherapy plus laryngeal function sparing surgery].
Huang H; Zhang ZM; Zhang Y; Wang XL; Liu SY; Xu ZG
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):535-539. PubMed ID: 31357842
[No Abstract] [Full Text] [Related]
5. Oncological and functional outcomes of trans-oral robotic surgery for pyriform sinus carcinoma: A French GETTEC group study.
Mazerolle P; Philouze P; Garrel R; Aubry K; Morinière S; El Bedoui S; Ton Van J; Ferron C; Malard O; Jegoux F; Berard E; Vergez S
Oral Oncol; 2018 Nov; 86():165-170. PubMed ID: 30409296
[TBL] [Abstract][Full Text] [Related]
6. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
[TBL] [Abstract][Full Text] [Related]
7. Predicting Factors for Oncological and Functional Outcome in Hypopharyngeal Cancer.
Visini M; Giger R; Shelan M; Elicin O; Anschuetz L
Laryngoscope; 2021 May; 131(5):E1543-E1549. PubMed ID: 33098325
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
[TBL] [Abstract][Full Text] [Related]
9. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
Lefebvre JL; Chevalier D; Luboinski B; Kirkpatrick A; Collette L; Sahmoud T
J Natl Cancer Inst; 1996 Jul; 88(13):890-9. PubMed ID: 8656441
[TBL] [Abstract][Full Text] [Related]
10. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
Karp DD; Vaughan CW; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong MS; Hong WK
Am J Clin Oncol; 1991 Aug; 14(4):273-9. PubMed ID: 1713738
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer.
Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Int J Clin Oncol; 2015 Dec; 20(6):1081-5. PubMed ID: 25804347
[TBL] [Abstract][Full Text] [Related]
12. Rational choice of induction chemotherapy-based larynx preservation for hypopharyngeal cancer.
Liu S; Fang J; Ma H; Meng L; Bai Y; Feng L; Lian M; Li P; Zhong Q; Hou L
Acta Otolaryngol; 2018 Dec; 138(12):1146-1153. PubMed ID: 30663475
[TBL] [Abstract][Full Text] [Related]
13. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
[No Abstract] [Full Text] [Related]
14. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function.
Samant S; Kumar P; Wan J; Hanchett C; Vieira F; Murry T; Wong FS; Robbins KT
Head Neck; 1999 Oct; 21(7):595-601. PubMed ID: 10487945
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.
Janoray G; Pointreau Y; Alfonsi M; Sire C; Geoffrois L; de Raucourt D; Bardet E; Calais MH; Garaud P; Calais G
Eur J Cancer; 2020 Jul; 133():86-93. PubMed ID: 32454417
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.
Forastiere AA; Zhang Q; Weber RS; Maor MH; Goepfert H; Pajak TF; Morrison W; Glisson B; Trotti A; Ridge JA; Thorstad W; Wagner H; Ensley JF; Cooper JS
J Clin Oncol; 2013 Mar; 31(7):845-52. PubMed ID: 23182993
[TBL] [Abstract][Full Text] [Related]
17. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma.
Prades JM; Lallemant B; Garrel R; Reyt E; Righini C; Schmitt T; Remini N; Saban-Roche L; Timoshenko AP; Trombert B; Guerrier B
Acta Otolaryngol; 2010; 130(1):150-5. PubMed ID: 19449227
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.
Paximadis P; Yoo G; Lin HS; Jacobs J; Sukari A; Dyson G; Christensen M; Kim H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1515-21. PubMed ID: 21658855
[TBL] [Abstract][Full Text] [Related]
20. Neck Management with Total Laryngectomy and Adjuvant Radiotherapy in Locally Advanced Larynx Cancer.
Kennedy WR; Amdur RJ; Boyce BJ; Dziegielewski P; Morris CG; Mendenhall WM
Oncol Res Treat; 2017; 40(9):503-506. PubMed ID: 28848123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
